4//SEC Filing
CHASE WILLIAM J 4
Accession 0000950170-25-110979
CIK 0001652130other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:30 PM ET
Size
5.1 KB
Accession
0000950170-25-110979
Insider Transaction Report
Form 4
CHASE WILLIAM J
Director
Transactions
- Purchase
Common Stock
2025-08-20$10.03/sh+100,000$1,003,000→ 134,693 total
Footnotes (2)
- [F1]Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.97 to $10.04, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on August 20, 2025 at each separate price.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001563572
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:30 PM ET
- Size
- 5.1 KB